跳至主要内容
临床试验/JPRN-UMIN000040390
JPRN-UMIN000040390已完成未知

Analysis of Blood Culture and antibacterial Drugs in Classical empiric therapy vs. D-index-guided early therapy using micafungin for persistent febrile neutropenia.(ABCD-CEDMIC trial) - Analysis of Blood Culture and antibacterial Drugs in RCT to compare empiric antifungal therapy and D-index-guided early therapy (ABCD-CEDMIC trial)

Japan Febrile Neutropenia Study Group0 个研究点目标入组 423 人开始时间: 2020年5月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
423

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 79years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Previous history of invasive fungal infection 2)Receiving antifungal agents other than prophylactic administration 3)Suspected active infection 4)Planned to receive antifungal prophylaxis with polyenes or candins 5)Allergic reaction to candins 6)Pregnant or possibly pregnant 7)HIV positive 8)Not suitable for thie trial judged by attending physicians

研究者

发起方
Japan Febrile Neutropenia Study Group

相似试验